Guerbet Displays New Multi-Use Injector at ECR 2019

Using a novel presentation concept developed in collaboration with the European Society of Radiology (ESR), the company enriched the visitors’ experience through a unique combination of integrated solutions and related educational program.

ECR visitors had the opportunity to explore the many Guerbet solutions that apply throughout the whole patient pathway: with contrast media and injection systems, including the new multi-patient solution: OptiVantage multi-use injector for CT diagnosis, and follow-up which answers market needs without compromising efficiency and patient safety. Launched in 2005, the OptiVantage injector is intended for use by medical imaging and diagnostic health professionals, for injecting radiopaque contrast media and saline into a patient’s vascular system during CT examinations. The new version is adapted to multi-use markets and is available in pedestal and ceiling-mount versions.

Guerbet also displayed its digital solutions, featuring Contrast&Care 2.0, a contrast media injection management solution aiming to improve both productivity of healthcare professionals and patient safety. Contrast&Care enables imaging centers to collect, archive, examine and share injection data, including data on contrast media, adverse events, injector activity, information on the estimated glomerular filtration rate (eGFR) and other risk factors before an exam. Contrast&Care 2.0 connects with all CT, Cath Lab and MRI injectors in the current Guerbet range.

Additionally, Guerbet also provided a comprehensive educational program with workshops and a symposium covering hot topics in modern diagnostic radiology such as AI, Gadolinium and brain deposition, contrast optimization, etc., as well as in interventional imaging (cTACE and liver imaging).